Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Jaguar Health, Inc. (JAGX) is a Biotechnology company based in US with a market capitalization of $211.9K. Revenue declined 1.5% year-over-year and the company generated $5.8M in free cash flow. This page tracks JAGX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 49 employees · IPO May 12, 2015
Valuation
Valuation & price
$2.91as of May 23, 2026· -96.8% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$211.9K
Market cap
-1.5%
Revenue growth (YoY)
67.2%
Gross margin
$5.8M
Free cash flow (USD)
$42.6M
Net debt
691.9%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 20, 2026 (EPS $-13.60)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 14, 2026Filing
Manufacturing Agreement
- 8-K eventJul 1, 2026Filing
Preferred Stock Conversion
- 8-K eventJun 25, 2026Filing
Manufacturing Agreement Amendment
- 8-K eventJun 22, 2026Filing
Strategic Alternatives Exploration
- 8-K eventJun 22, 2026Filing
Strategic Alternatives Exploration
- 8-K eventJun 18, 2026Filing
Royalty Interest Amendments
- 8-K eventJun 11, 2026Filing
Common Stock Purchase Agreement
- 8-K eventJun 8, 2026Filing
Annual Meeting Results
- 8-K eventJun 2, 2026Filing
Equity Exchange Agreement
- 8-K eventMay 27, 2026Filing
Compliance with Nasdaq Rule
Questions
Frequently asked questions
What is Jaguar Health, Inc.'s market cap?
Jaguar Health, Inc. (JAGX) has a market capitalization of $211.9K.
What is JAGX's P/E ratio?
A meaningful P/E ratio is not available for JAGX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
When did Jaguar Health, Inc. last report earnings?
JAGX last reported earnings on May 20, 2026; the next date is not yet scheduled.
Are insiders buying JAGX stock?
SEC Form 4 filings show no open-market insider buys at Jaguar Health, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.